Maximum likelihood perimetric progression analysis: Using raw (trial-by-trial) response data to estimate progression more robustly
View ORCID ProfilePete R. Jones
doi: https://doi.org/10.1101/2021.02.05.21251210
Pete R. Jones
1Division of Optometry and Visual Sciences, School of Health Science, City, University of London, London, England, EC1V 0HB
Data Availability
Source code provided as Supplemental Material
Posted February 08, 2021.
Maximum likelihood perimetric progression analysis: Using raw (trial-by-trial) response data to estimate progression more robustly
Pete R. Jones
medRxiv 2021.02.05.21251210; doi: https://doi.org/10.1101/2021.02.05.21251210
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)